Article

Accommodating IOL encouraging for pseudophakic patients

The accommodating IOL (Crystalens, eyeonics) appears promising in providing pseudophakic patients with enough pseudoaccommodation to function without near glasses, said George I. Papastergiou, MD.

New Orleans-The accommodating IOL (Crystalens, eyeonics) appears promising in providing pseudophakic patients with enough pseudoaccommodation to function without near glasses, said George I. Papastergiou, MD.

He presented data from 83 eyes of 44 patients (ages 42 to 74 years old) who were followed for up to 3 years. At 2 weeks after surgery, all eyes showed excellent IOL centration, none had flare or cells in the anterior chamber, IOP was consistently

At last available follow-up, 100% of eyes had distance UCVA of 20/40 and 88% saw 20/25 or better, although nine eyes underwent LASIK for >1 D of residual myopia.

Near UCVA was J4 or better in 100% of eyes and J3 or better in 93.8%, and all eyes could read J4 or better through distance correction. Accommodative range by defocusing was between 0.75 and 2.0 D and appeared stable throughout the study, averaging 1.65 D at 1 month and 1.48 D at 36 months.

Dr. Papastergiou reported 23 eyes required Nd:YAG capsulotomy. While they initially presented with regression of the accommodative effect, they improved following the capsulotomy with a mean change of 0.22 D.

"We have found high patient satisfaction in this group, although we caution surgeons to be careful in selecting candidates. Since the optic is only 4.5 mm, we implant this accommodating IOL only in eyes with a scotopic pupil

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.